1. Home
  2. |Insights
  3. |DoD IG Signals Shift in FOIA Policy

DoD IG Signals Shift in FOIA Policy

Client Alert | less than 1 min read | 08.18.16

In June, the DoD IG announced that, "[i]n an effort to create greater transparency, DoD OIG will proactively redact and post reports and select administrative investigations," rather than requiring FOIA requests for them. Along with the recent amendments to FOIA, which require agencies to "make available for public inspection in an electronic format" records "that have been requested three or more times," the IG's decision is likely to increase the amount of information available to the public regarding IG reports, which in the past have included investigations of major defense programs.

Insights

Client Alert | 2 min read | 09.18.25

FDA Announces Intention to Initiate an Aggressive Enforcement Campaign Against Misleading Pharmaceutical Advertising

On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”...